EV/EBITDA
-0.11
+0.01+8.33%
3 min ago
Summary
- As of February 7, 2025, NMRA EV/EBITDA is -0.11, with a rise of +0.01 (+8.33%) during the most recent trading day.
- Over the past year, NMRA EV/EBITDA has increased by +9.14 (+98.81%).
- NMRA EV/EBITDA is now -10.00% below its all-time high of -0.10.
Performance
NMRA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NMRA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +8.3% | -8.8% | -1.1% |
| 1 m1 month | +77.5% | -78.1% | -28.3% |
| 3 m3 months | +98.0% | -98.0% | -84.6% |
| 6 m6 months | +98.1% | -98.0% | -83.9% |
| ytdytd | +97.6% | -97.6% | -82.1% |
| 1 y1 year | +98.8% | -98.5% | -88.8% |
| 5 y5 years | - | - | - |
NMRA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.0% | -0.49 | +77.5% | |
| 3 m | 3-month | -0.10 | -10.0% | -6.20 | +98.2% |
| 6 m | 6-month | -0.10 | -10.0% | -8.00 | +98.6% |
| 1 y | 1-year | -0.10 | -10.0% | -11.02 | +99.0% |
| 3 y | 3-year | -0.10 | -10.0% | -16.01 | +99.3% |
| 5 y | 5-year | -0.10 | -10.0% | -16.01 | +99.3% |
| alltime | all time | -0.10 | -10.0% | -16.01 | +99.3% |
Neumora Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.11(-97.6%) |
| Date | Value |
|---|---|
| 2024 | -4.59(-50.6%) |
| 2023 | -9.30 |
FAQ
- What is Neumora Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Neumora Therapeutics?
- What is NMRA EV/EBITDA year-to-date change?
- What is Neumora Therapeutics EV/EBITDA year-on-year change?
What is Neumora Therapeutics EV/EBITDA?
The current EV/EBITDA of NMRA is -0.11
What is the all time high EV/EBITDA for Neumora Therapeutics?
Neumora Therapeutics all-time high EV/EBITDA is -0.10
What is NMRA EV/EBITDA year-to-date change?
Neumora Therapeutics EV/EBITDA has changed by +4.48 (+97.60%) since the beginning of the year
What is Neumora Therapeutics EV/EBITDA year-on-year change?
Over the past year, NMRA EV/EBITDA has changed by +9.14 (+98.81%)